)
Agilent Technologies (A) investor relations material
Agilent Technologies 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic priorities and market positioning
Focused on large, high-growth markets with secular drivers, including pharma, biotech, diagnostics, and applied markets, targeting $83B markets with 5-7% long-term core growth.
Emphasis on customer-centricity, innovation, and leveraging the Ignite operating system for transformation and efficiency.
Two-thirds of revenue now comes from recurring sources like consumables, services, and software, enhancing resilience; revenue mix for these segments grew 700bps over five years.
Balanced global footprint, serving over 285,000 labs in 110 countries, with strong digital channel growth and 40% of orders now digital.
Leading positions in chromatography, mass spectrometry, and spectroscopy, with customer retention rates above 90%.
Growth drivers and innovation
Accelerating replacement cycles in LC and GC instruments, with significant productivity improvements and extended growth runway.
Specialty CDMO growth driven by complex molecule outsourcing, strong GLP-1 and siRNA demand, and new siRNA API capacity coming in 2027 to double NASD revenue potential.
Expansion in applied markets, especially PFAS testing, semiconductors, and battery testing.
Digital and AI investments to enhance lab productivity and customer engagement, with AI focus ramping up in 2026.
New product launches, such as the Altero Ultra Inert Column, Pro iQ Plus, and Infinity III LC, driving portfolio growth and differentiation.
Financial outlook and capital allocation
FY26 guidance projects net revenue of $7.3B–$7.4B, core revenue growth of 4–6%, and EPS of $5.86–$6.00, underpinned by high single-digit pharma growth.
Operating margin expansion of 50-100 basis points expected, with Ignite driving pricing and efficiency gains; FY25 operating margin was 25.7% (non-GAAP).
China revenue expected to remain flat in FY26, with long-term optimism tied to innovation and regulatory trends.
Specialty CDMO expected to grow at mid-teens rate in 2026, with strong order momentum in GLP-1 and siRNA.
Disciplined M&A approach focused on strategic fit, recurring revenue, and integration capability, with no size limitations.
Next Agilent Technologies earnings date
Next Agilent Technologies earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Enabling Laboratory Work
Agilent Technologies is an American company with a global reach, headquartered in Santa Clara, California. It specializes in providing software, instruments, services, and other similar products for laboratories, hospitals, and the broader life science industry. The company was established in 1999 as the result of a spin-off from several different branches of Hewlett Packard and is listed on the NYSE.
What They Do
Agilent Technologies specializes in the development and manufacturing of analytical instruments, software, services, and consumables that scientists, researchers, and doctors employ across a range of sectors.
In life sciences, Agilent provides solutions for pharmaceutical, biotechnology, and academic research, supplying the tools that are critical discoveries and advancements. In diagnostics, the company offers tools and technologies that assist healthcare professionals in disease detection, monitoring, and treatment. Furthermore, in the applied chemical sector, Agilent's products are used in industries such as food testing, environmental monitoring, and forensics, ensuring quality, safety, and regulatory compliance
Spin-Off From Hewlett Packard
Agilent Technologies was established in 1999 as a spin-off from Hewlett-Packard (HP), continuing HP's legacy in the electronic and bio-analytical measurement sectors. The resulting IPO of Agilent stock became a massive deal in Silicon Valley at the time and marked the largest in its history. The creation of Agilent was a strategic move to allow it to focus intently on life sciences, diagnostics, and applied chemical markets. This dedicated focus allowed Agilent to quickly establish itself as one of the leaders in its chosen markets.
Forming of Keysight
But that wasn’t the end of the spin-offs. Up until 2014, Agilent produced semiconductors, optics, EDA software, and various types of measurement equipment. This segment of the company was spun off to form Keysight, while Agilent continued to focus on its core products and specialties.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)